Linette Lopez

ReutersJonathan Roper (2nd L), a former Insys Therapeutics Inc district sales manager, and Fernando Serrano (C), a former sales representative at the company walk with Serrano's lawyer, Jude Cardenas (R), out of federal court after they pleaded not guilty to engaged in a scheme to pay doctors kickbacks to prescribe a fentanyl-based drug the company sells, in Manhattan, New York, U. S.

Screenshot, 23WIFRRockford, Illinois Mayor Larry MorrisseyThe town of Rockford, Illinois is suing Mallinckrodt Pharmaceuticals over the price of one of its blockbuster drugs, called Acthar. Rockford is accusing Mallinckrodt of taking advantage of its monopoly of the market and charging an exorbitant price for the drug around 35,000 per vial.

Elon Musk has started an electric-vehicle price war that Tesla can’t finish.Under increasing pressure from new competition, Tesla spent the past year slashing the average price of its models by roughly 25%. The Model 3 fell from $48,000 to $44,380. The luxury Model S, meanwhile, plunged from a high of $130,000 to $96,380. The cars, as they say, have been priced to move.It’s an unusual business strategy, to put it mildly. “I can’t think of another point in the history of automotive when a brand t…

MareaIn the staid, reputation-conscious world of New York fine dining, it is incredibly rare for a restaurant to take a swing at the New York Times over a

MareaIn the staid, reputation-conscious world of New York fine dining, it is incredibly rare for a restaurant to take a swing at the New York Times over a

Bodega NegraA private room in Bodega Negra.One of the beautiful things about New York City is that hotels aren’t just hotels, they’re adult playgrounds. And like playgrounds they’ve got jungle gyms (world-famous clubs) and hot dog stands (killer restaurants). But unlike playgrounds, they’re constantly competing for (your) attention. Without question The Dream Hotel Downtown, home of rooftop nightclub PH-D, has Wall Street’s fullest. Soon so will its new restaurant, Bodega Negra. We’ll keep this…